Albireo Pharma (ALBO)

Albireo Pharma (ALBO) Financial Statements


Albireo Pharma Financial Overview

Albireo Pharma's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Albireo Pharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 9.83M$ 8.21M$ 6.83M$ 32.52M$ 3.66M
Gross Profit$ 9.22M$ 7.43M$ 6.60M$ 31.60M$ 3.23M
EBIT$ -35.27M$ -37.20M$ -39.56M$ -11.49M$ 64.21M
EBITDA$ -35.15M$ -37.12M$ -39.44M$ -11.39M$ 64.30M
Net Income Common Stockholders$ -37.80M$ -39.95M$ -42.43M$ -10.96M$ 57.09M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 222.48M$ 180.97M$ 216.66M$ 248.11M$ 262.61M
Total Assets$ 321.22M$ 229.01M$ 261.26M$ 302.05M$ 296.44M
Total Debt$ 0.00$ 10.16M$ 10.08M$ 10.00M$ 9.93M
Net Debt$ -222.48M$ -170.81M$ -206.57M$ -238.10M$ -252.68M
Total Liabilities$ 221.15M$ 115.34M$ 113.08M$ 126.44M$ 114.73M
Stockholders Equity$ 100.07M$ 113.68M$ 148.19M$ 175.61M$ 181.72M
Cash Flow-
Free Cash Flow$ -29.67M$ -37.08M$ -35.64M$ -13.89M$ -27.67M
Operating Cash Flow$ -29.63M$ -36.39M$ -35.41M$ -13.89M$ -27.48M
Investing Cash Flow$ -40.00K$ -685.00K$ -235.00K$ 0.00$ 103.20M
Financing Cash Flow$ 121.48M$ 1.80M$ 4.38M$ 370.00K$ 762.00K
Currency in USD

Albireo Pharma Earnings and Revenue History

Albireo Pharma Debt to Assets

Albireo Pharma Cash Flow

Albireo Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis